'Pharmacist only' medicines

Australian and New Zealand Journal of Public Health

Volumn 23, Issue 6, 1999, Pages 661-662

  Bessell, Tracey L ^a   Hiller, Janet E ^a   Sansom, Lloyd N ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; NON PRESCRIPTION DRUG;

ARTICLE; AUSTRALIA; DRUG INFORMATION; DRUG LEGISLATION; HEALTH CARE POLICY; MEDICAL DECISION MAKING; PHARMACIST; PRESCRIPTION; PUBLIC HEALTH;

EID: 0033384778     PISSN: 13260200     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-842X.1999.tb01557.x     Document Type: Article

References (8)

1. Australian Health Ministers' Advisory Council. Guidelines for National Drugs and Poisons Schedule Committee. Canberra: AGPS, 1997.
2. Ferris DG, Dekle C, Litaker MS. Women's Use of Over-the-Counter Antifungal Medications for Gynecologic Symptoms. J Fam Pract 1996; 42: 595-600.
3. Reef SE, Levine WC, McNeil MM, et al. Treatment options for vulvovaginal candidiasis 1993 [online], The Cochrane Library, The Cochrane Collaboration issue no.: 2. [Oxford]: Update Software, 1998 [cited 6 July 1998]. Updated quarterly. Available from Internet: URL: http://www.nhsord.york.ac.uk/ cgi-bin/vl.engine. DARE-950851. Also available database on disk and CD-Rom.
4. Commonwealth Department of Health and Family Services. Review of the Therapeutic Goods Administration. Canberra: AGPS, 1997.
5. Commonwealth Department of Health and Family Services. The Pharmaceutical Benefits Scheme. Canberra: AGPS, 1997.
6. Consumers' Health Forum of Australia. Pharmaceuticals Project Final Report. Canberra: AGPS, 1995.
7. Editorial. Poisons Scheduling Review. Aust J Pharm 1998; 79(11): 1226.
8. Sansom LN. The Australian National Medicinal Drug Policy. J Qual Clin Pract 1999; 19: 31-5.